Cite
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis
MLA
Jeong Won Baek, et al. “Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis.” Pharmaceuticals, vol. 14, no. 512, May 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....83708987059697337f2da442c57352e8&authtype=sso&custid=ns315887.
APA
Jeong Won Baek, Kwang Min Lee, Seungje Jeon, Chul-Seung Park, & Seung-Joo Yang. (2021). Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis. Pharmaceuticals, 14(512).
Chicago
Jeong Won Baek, Kwang Min Lee, Seungje Jeon, Chul-Seung Park, and Seung-Joo Yang. 2021. “Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4CRBN Protein Degradation Axis.” Pharmaceuticals 14 (512). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....83708987059697337f2da442c57352e8&authtype=sso&custid=ns315887.